These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25520598)

  • 1. Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro.
    Imai S; Yoshioka Y; Morishita Y; Yoshida T; Uji M; Nagano K; Mukai Y; Kamada H; Tsunoda S; Higashisaka K; Tsutsumi Y
    Nanoscale Res Lett; 2014; 9(1):651. PubMed ID: 25520598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption and biological effects of orally administered amorphous silica particles.
    Yoshida T; Yoshioka Y; Takahashi H; Misato K; Mori T; Hirai T; Nagano K; Abe Y; Mukai Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Higashisaka K; Tsutsumi Y
    Nanoscale Res Lett; 2014; 9(1):532. PubMed ID: 25288919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of nanosilica particle-induced inflammation by surface modification of the particles.
    Morishige T; Yoshioka Y; Inakura H; Tanabe A; Narimatsu S; Yao X; Monobe Y; Imazawa T; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
    Arch Toxicol; 2012 Aug; 86(8):1297-307. PubMed ID: 22418595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice.
    Yoshida T; Yoshioka Y; Tochigi S; Hirai T; Uji M; Ichihashi K; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Higashisaka K; Yoshikawa T; Tsutsumi Y
    Part Fibre Toxicol; 2013 Aug; 10():41. PubMed ID: 23958113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells.
    Yoshida T; Yoshioka Y; Matsuyama K; Nakazato Y; Tochigi S; Hirai T; Kondoh S; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Tsutsumi Y
    Biochem Biophys Res Commun; 2012 Nov; 427(4):748-52. PubMed ID: 23044420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of silica nanoparticle binding to major human blood proteins.
    Hata K; Higashisaka K; Nagano K; Mukai Y; Kamada H; Tsunoda S; Yoshioka Y; Tsutsumi Y
    Nanoscale Res Lett; 2014 Dec; 9(1):2493. PubMed ID: 26089000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice.
    Yoshida T; Yoshioka Y; Morishita Y; Aoyama M; Tochigi S; Hirai T; Tanaka K; Nagano K; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Higashisaka K; Tsutsumi Y
    Nanotechnology; 2015 Jun; 26(24):245101. PubMed ID: 26011124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages.
    Nabeshi H; Yoshikawa T; Arimori A; Yoshida T; Tochigi S; Hirai T; Akase T; Nagano K; Abe Y; Kamada H; Tsunoda S; Itoh N; Yoshioka Y; Tsutsumi Y
    Nanoscale Res Lett; 2011 Jan; 6(1):93. PubMed ID: 21711578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice.
    Qin CZ; Lv QL; Wu NY; Cheng L; Chu YC; Chu TY; Hu L; Cheng Y; Zhang X; Zhou HH
    J Ethnopharmacol; 2015 Jun; 168():146-9. PubMed ID: 25858508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Skin Permeability and Toxicological Properties of Amorphous Silica Particles.
    Matsuo K; Hirobe S; Okada N; Nakagawa S
    Biol Pharm Bull; 2016; 39(7):1201-5. PubMed ID: 27374294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice.
    Yoshida T; Yoshioka Y; Fujimura M; Yamashita K; Higashisaka K; Morishita Y; Kayamuro H; Nabeshi H; Nagano K; Abe Y; Kamada H; Tsunoda S; Itoh N; Yoshikawa T; Tsutsumi Y
    Nanoscale Res Lett; 2011 Mar; 6(1):195. PubMed ID: 21711705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying the Surface of Silica Nanoparticles with Amino or Carboxyl Groups Decreases Their Cytotoxicity to Parenchymal Hepatocytes.
    Nagano T; Nagano K; Nabeshi H; Yoshida T; Kamada H; Tsunoda SI; Gao JQ; Higashisaka K; Yoshioka Y; Tsutsumi Y
    Biol Pharm Bull; 2017; 40(5):726-728. PubMed ID: 28458361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of calcium flux from the extracellular region and endoplasmic reticulum by amorphous nano-silica particles owing to carboxy group addition on their surface.
    Onodera A; Yayama K; Morosawa H; Ishii Y; Tsutsumi Y; Kawai Y
    Biochem Biophys Rep; 2017 Mar; 9():330-334. PubMed ID: 29114587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of salvianolate on human cytochrome P450 3A4 in vitro involving a noncompetitive manner.
    Qin CZ; Ren X; Zhou HH; Mao XY; Liu ZQ
    Int J Clin Exp Med; 2015; 8(9):15549-55. PubMed ID: 26629047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4.
    Lv QL; Wang GH; Chen SH; Hu L; Zhang X; Ying G; Qin CZ; Zhou HH
    Int J Environ Res Public Health; 2015 Dec; 13(1):84. PubMed ID: 26712778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.
    Toda T; Yoshino S
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):408-20. PubMed ID: 27343242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC; Wallace AD; Hodgson E; Rose RL
    Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a highly reproducible system to evaluate inhibition of cytochrome P450 3A4 activity by natural medicines.
    Sato Y; Sasaki T; Takahashi S; Kumagai T; Nagata K
    J Pharm Pharm Sci; 2015; 18(4):316-27. PubMed ID: 26626238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.